Clinical trial · Observational
Non-alcoholic Fatty Liver Disease in Women With Polycystic Ovary Syndrome
Assessment of Non-alcoholic Fatty Liver Disease and Risk Factors in Women With Polycystic Ovary Syndrome
NCT05843955CI-TRIAL-00066237completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study was planned to examine the prevalence of vitamin D insufficiency, insulin resistance, non-alcoholic fatty liver disease (NAFLD), and their relationship with each other and the nutritional status of individuals with polycystic ovary syndrome (PCOS) in reproductive age, by evaluating anthropometric, biochemical, and ultrasonographic findings and food consumption frequency data.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| NAFLD | — | UNRESOLVED | — |
| PCOS | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Questionnaire | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Women with Polycystic ovary syndrome (PCOS)
- description
- PCOS was diagnosed according to the revised 2003 Rotterdam Consensus as the presence of at least two of the following three criteria: (i)oligomenorrhoea or anovulation; (ii)clinical and/or biochemical signs of hyperandrogenemia and (iii)polycystic ovaries on ultrasound.
- interventionNames
- Other: Questionnaire
Primary outcomes (3)
- measure
- Serum vitamin D levels
- timeFrame
- 3 months
- description
- Serum vitamin D levels were measured by immunoassay analyzer.
- measure
- Insulin resistance
- timeFrame
- 3 months
- description
- Insulin resistance analyzed by homeostasis model assessment-insulin resistance (HOMA-IR) formulation.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 19 Years
- Maximum age
- 40 Years
Show eligibility criteria text
Inclusion Criteria: * female sex * PCOS diagnosis * no use of oral contraceptives or any hormone therapy in the last 3 months * no use of vitamin D supplements in the last 3 months * no use of oral antidiabetic drugs in the last 3 months Exclusion Criteria: * adrenal dysfunction * diabetes mellitus * pregnancy * alcohol consumption * a history of chronic viral hepatitis * autoimmune liver disease * other liver diseases * history of hepatotoxicity * use of antihypertensive, antidiabetic, lipid-lowering drugs
References
Publications (0)
Data not yet available
No reference posted for this study.